HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laura Sanz Selected Research

Norgestrienone (A 301)

5/2005Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laura Sanz Research Topics

Disease

36Neoplasms (Cancer)
01/2022 - 05/2002
4Malaria
01/2018 - 07/2004
3Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 01/2013
3Fibrosarcoma
01/2011 - 05/2005
2Breast Neoplasms (Breast Cancer)
01/2019 - 05/2005
2Inflammation (Inflammations)
05/2016 - 05/2015
2Communicable Diseases (Infectious Diseases)
05/2015 - 08/2013
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Leukemia
01/2022
1Multiple Myeloma
01/2019
1Cytokine Release Syndrome
01/2017
1Falciparum Malaria (Plasmodium falciparum Malaria)
01/2017
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2016
1Prostatic Neoplasms (Prostate Cancer)
08/2013
1Alzheimer Disease (Alzheimer's Disease)
08/2013
1Substance-Related Disorders (Drug Abuse)
08/2013
1Carcinoma (Carcinomatosis)
01/2009
1Melanoma (Melanoma, Malignant)
01/2007
1Experimental Melanoma
07/2005
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2002

Drug/Important Bio-Agent (IBA)

10AntibodiesIBA
01/2022 - 02/2004
9AntigensIBA
01/2022 - 02/2004
7Bispecific AntibodiesIBA
01/2022 - 01/2014
6Monoclonal AntibodiesIBA
11/2021 - 12/2005
3Immunoglobulin FragmentsIBA
01/2009 - 10/2003
2Chimeric Antigen ReceptorsIBA
01/2022 - 01/2019
2Immunotoxins (Immunotoxin)IBA
11/2021 - 01/2019
2Proteins (Proteins, Gene)FDA Link
01/2019 - 05/2005
2Therapeutic UsesIBA
01/2019 - 05/2015
2Single-Domain AntibodiesIBA
11/2018 - 01/2017
2Single-Chain AntibodiesIBA
11/2018 - 01/2017
2Immunoglobulin G (IgG)IBA
11/2018 - 07/2005
2Collagen Type XVIII (Type XVIII Collagen)IBA
11/2018 - 07/2006
2Pharmaceutical PreparationsIBA
01/2017 - 12/2014
2Tumor Biomarkers (Tumor Markers)IBA
05/2015 - 08/2013
2CollagenIBA
03/2012 - 01/2009
2Carcinoembryonic AntigenIBA
09/2009 - 01/2009
2Peptide Hydrolases (Proteases)FDA Link
07/2006 - 06/2003
1Epithelial Cell Adhesion MoleculeIBA
01/2022
1blinatumomabIBA
01/2022
1Insulin-Like Growth Factor Binding Protein 3IBA
10/2020
1Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA
01/2020
1ErbB Receptors (EGF Receptor)IBA
01/2018
1artemisinin (artemisinine)IBA
01/2017
1Muromonab-CD3 (Muromonab CD3)FDA Link
01/2017
1NucleotidesIBA
05/2016
1SJ733IBA
12/2014
1Proteasome Endopeptidase Complex (Proteasome)IBA
08/2013
1Retinaldehyde (Retinal)IBA
08/2013
1RNA (Ribonucleic Acid)IBA
01/2013
1Bevacizumab (Avastin)FDA Link
01/2013
1Formaldehyde (Formol)FDA Link
01/2013
1ParaffinIBA
01/2013
1Biomarkers (Surrogate Marker)IBA
01/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013
1matrigelIBA
01/2011
1Neoplasm Antigens (Tumor Antigens)IBA
09/2009
1Surface Antigens (Surface Antigen)IBA
09/2009
1Laminin (Merosin)IBA
01/2009
1EpitopesIBA
01/2009
1Chemokine CCL21IBA
01/2007
1ChemokinesIBA
01/2007
1EndostatinsIBA
07/2006
1Angiogenesis InhibitorsIBA
07/2006
1DNA (Deoxyribonucleic Acid)IBA
04/2006
1Cancer VaccinesIBA
04/2006
1Fc Receptors (Fc Receptor)IBA
07/2005
1Immunoglobulin Fc FragmentsIBA
07/2005
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
07/2005
1Complementary DNA (cDNA)IBA
07/2005
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
07/2005
1Norgestrienone (A 301)IBA
05/2005
1FurinIBA
05/2005
1IntegrinsIBA
06/2003
1Integrin alpha4beta1 (VLA-4)IBA
03/2002
1fludarabineIBA
03/2002
1Fibronectins (Fibronectin)IBA
03/2002

Therapy/Procedure

20Therapeutics
01/2022 - 05/2002
8Immunotherapy
01/2022 - 03/2009
1Microspheres (Microsphere)
01/2018
1Drug Therapy (Chemotherapy)
01/2013